ArticleCancer2025

Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial.

Ming Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.